Several members of the ADAM family are highly expressed in a variety of human carcinomas, likely contributing to tumor development and/or progression through the release of epidermal growth factor receptor EGFR ligands or effects on cell-cell or cell-matrix adhesion [1], [3]. The gene discussed is EGFR; the disease is neoplasm.